SNWV MEXC RealStocks
Own real SNWV shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:33:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
SANUWAVE Health, Inc. (SNWV) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.70, with a market capitalization of $15.57M and a P/E ratio of 5.69. Over the past 52 weeks, its price has ranged from $1.55 to $35.29. This page covers its latest market performance, valuation, price trends and company information.
$15.57M | |
$1.70 | |
$1.80 | |
$1.60 | |
$1.70 | |
95.03K | |
79.05K | |
5.69 | |
$35.29 | |
$1.55 | |
-- | |
2026-09-30 |
SANUWAVE Health, Inc. (SNWV) last closed at $1.70 as of 2026-11-19 00:56:00, up 3.24% ($0.05) from the previous close of $1.70.
During the latest regular trading session, SNWV traded between $1.60 and $1.80, with a volume of 95.03K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, SANUWAVE Health, Inc. (SNWV) moved from $1.85 to $1.70, representing a decline of 8.00% ($0.15).
The stock traded between $1.55 and $2.23 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 123.53 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.5%
SNWV is currently trading at $1.70, placing it 0.5% of the way from its 52-week low of $1.55 to its 52-week high of $35.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 55 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SANUWAVE Health, Inc. (SNWV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SNWV, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SNWV shares and USD.
SNWV Shares to USD
1.00 SNWV shares = 1.702 USD
Calculations are estimates based on the latest available price and are for reference only.